Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,147,495	2,070,836	2,160,985	1,772,562	1,445,936	1,144,619
Market Cap Growth	-11.76%	-4.17%	21.91%	22.59%	26.32%	-6.40%
Enterprise Value	1,968,618	1,887,653	1,963,990	1,554,755	1,271,432	1,019,893
Last Close Price	8370.00	8242.96	8348.81	6857.85	5592.00	4602.00
PE Ratio	30.17	29.10	-	28.97	22.31	23.84
PS Ratio	9.94	9.58	9.41	10.62	8.30	7.37
PB Ratio	6.39	6.16	6.32	5.96	5.33	5.53
P/TBV Ratio	6.95	6.71	7.15	6.70	6.07	6.42
P/FCF Ratio	37.35	36.02	-	31.42	18.89	23.18
P/OCF Ratio	32.85	31.68	-	29.64	17.95	21.12
EV/Sales Ratio	9.43	8.74	8.55	9.32	7.30	6.57
EV/EBITDA Ratio	22.15	21.55	20.59	20.54	14.40	12.38
EV/EBIT Ratio	24.15	22.37	21.45	21.35	14.89	12.78
EV/FCF Ratio	34.24	32.83	-	27.56	16.61	20.66
Debt / Equity Ratio	0.11	0.11	0.11	0.05	0.07	0.10
Debt / EBITDA Ratio	0.40	0.40	0.37	0.18	0.20	0.24
Debt / FCF Ratio	0.64	0.64	-	0.24	0.23	0.40
Net Debt / Equity Ratio	-0.55	-0.55	-0.58	-0.73	-0.72	-0.65
Net Debt / EBITDA Ratio	-2.11	-2.11	-2.07	-2.88	-2.21	-1.63
Net Debt / FCF Ratio	-3.22	-3.22	11.99	-3.87	-2.54	-2.72
Asset Turnover	0.50	0.50	0.49	0.48	0.57	0.60
Inventory Turnover	3.85	3.85	5.31	7.38	8.87	8.97
Quick Ratio	2.24	2.24	2.17	3.60	4.46	4.04
Current Ratio	2.90	2.90	2.69	3.99	4.83	4.46
Return on Equity (ROE)	22.54%	22.54%	-3.15%	22.99%	27.67%	24.93%
Return on Assets (ROA)	12.16%	12.16%	12.14%	13.17%	17.33%	19.32%
Return on Invested Capital (ROIC)	29.60%	30.54%	-98.60%	63.54%	90.72%	102.53%
Return on Capital Employed (ROCE)	21.50%	21.50%	23.20%	22.50%	28.40%	34.50%
Earnings Yield	3.31%	3.44%	-0.52%	3.45%	4.48%	4.20%
FCF Yield	2.68%	2.78%	-0.76%	3.18%	5.29%	4.31%
Buyback Yield / Dilution	-0.04%	-0.04%	1.00%	-0.54%	0.31%	1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.